287 related articles for article (PubMed ID: 15372372)
1. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].
Schwertz H; Müller-Werdan U; Prondzinsky R; Werdan K; Buerke M
Dtsch Med Wochenschr; 2004 Sep; 129(37):1925-30. PubMed ID: 15372372
[TBL] [Abstract][Full Text] [Related]
2. Use of catecholamines in acute myocardial infarction.
Dixon DW; Loeb HS; Gunnar RM
Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic support in cardiogenic shock.
Rude RE
Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
[TBL] [Abstract][Full Text] [Related]
4. [Catecholamines for treatment of severe heart failure (author's transl)].
Mäurer W; Tillmanns H; Kübler W
Z Kardiol; 1979 May; 68(5):290-7. PubMed ID: 223342
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacotherapy of cardiogenic shock].
Ritz R
Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169
[TBL] [Abstract][Full Text] [Related]
6. [Catecholamines in internal medicine emergencies].
Brandt D; Pristautz H; Klein W
Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
Baumann G; Hader O
Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
9. [Dobutamine, dopamine, and other catecholamine-like substances for myocardial infarct].
Machii K
Nihon Rinsho; 1983 Dec; 41(12):2685-90. PubMed ID: 6674555
[No Abstract] [Full Text] [Related]
10. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
Flammang D; Sebastien P; Bouvrain Y
Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
[TBL] [Abstract][Full Text] [Related]
12. [High-dose nitroglycerin in cardiogenic shock].
Guglina ME
Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.
Schreiber W; Herkner H; Koreny M; Bur A; Hirschl MM; Glogar D; Huber K; Laggner AN
Resuscitation; 2002 Dec; 55(3):269-76. PubMed ID: 12458064
[TBL] [Abstract][Full Text] [Related]
14. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Kleinschmidt R; Spannbrucker N; Vogel F
Dtsch Med Wochenschr; 1985 Apr; 110(15):598-603. PubMed ID: 2983969
[No Abstract] [Full Text] [Related]
15. [Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
Chiche P; Baligadoo S
Ann Anesthesiol Fr; 1975 Dec; 16(9):705-10. PubMed ID: 5034
[TBL] [Abstract][Full Text] [Related]
16. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
Katz JN; Stebbins AL; Alexander JH; Reynolds HR; Pieper KS; Ruzyllo W; Werdan K; Geppert A; Dzavik V; Van de Werf F; Hochman JS;
Am Heart J; 2009 Oct; 158(4):680-7. PubMed ID: 19781431
[TBL] [Abstract][Full Text] [Related]
17. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
[TBL] [Abstract][Full Text] [Related]
18. [Sympathomimetic amines].
Benzer H
Anaesthesist; 1979 Apr; 28(4):153. PubMed ID: 434429
[No Abstract] [Full Text] [Related]
19. ["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].
Lupi Herrera E; Chuquiure Valenzuela E; González Pacheco H; Cuéllar Velasco BM; Arias Mendoza A; Martínez Sánchez CR
Arch Cardiol Mex; 2006; 76(1):95-108. PubMed ID: 16749510
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial.
White HD; Palmeri ST; Sleeper LA; French JK; Wong CK; Lowe AM; Crapo JW; Koller PT; Baran KW; Boland JL; Hochman JS; Wagner GS;
Am Heart J; 2004 Nov; 148(5):810-7. PubMed ID: 15523311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
